Global News and Digital Insights
for the Healthcare Industry

EnsoData reveals AI-powered solution that will diagnose patients while they sleep

EnsoData has revealed its AI solution for exploring the role of sleep in human health and the diseases it may entail, which is a crucial in addressing healthcare issues such as access to primary care, affordability, and workforce burnout. This artificial intelligence solution will assist in the detection of sleep apnea, a disease that is otherwise undiagnosed. EnsoData is rapidly offering AI-driven solutions and has helped over 50,000 patients in collaboration with 100 provider organisations across the US. The firm has closed a deal at $20 million Series A extension, with Inspire Medical Systems as the primary lead while also including investors Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 Ventures.

Read More from AITHORITY

Share on facebook
Share on twitter
Share on linkedin